[1] [1] FITZMAURICE C, ABATE D, ABBASI N, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990—2019: a systematic analysis for the Global Burden of Disease Study 2019［J］. Lancet, 2020, 396(10258): 1204-1222.

[2] [2] DEMBIC Z. Antitumor drugs and their targets［J］. Molecules, 2020, 25(23): 5776.

[3] [3] DASKALAKIS K, NORLéN O, KARAKATSANIS A, et al.?Ex vivo?activity of cytotoxic drugs and targeted agents in small intestinal neuroendocrine tumors［J］. Endocrine Related Cancer, 2018, 25(4): 471-480.

[4] [4] GROENLAND S L, VAN NULAND M, VERHEIJEN R B, et al. Therapeutic drug monitoring of oral anti-hormonal drugs in oncology［J］. Clinical Pharmacokinetics, 2019, 58(3): 299-308.

[5] [5] BUC M. New biological agents in the treatment of multiple sclerosis［J］. Bratislavske Lekarske Listy, 2018, 119(4): 191-197.

[6] [6] KOLLáR é, BALáZS B, TARI T, et al. Development challenges of high concentration monoclonal antibody formulations［J］. Drug Discovery Today Technologies, 2020, 37: 31-40.

[7] [7] SIMM C, MAY R C. Zinc and iron homeostasis: target-based drug screening as new route for antifungal drug development［J］. Frontiers in Celluar and Infection Microbiology, 2019, 29: 9-18.

[8] [8] MA J, CAO Q, MCLEOD S M, et al. Target-based whole-cell screening by HNMR spectroscopy［J］. Angewandte Chemie-International Edition, 2015, 54(16): 4764-4767.

[9] [9] TAOUQI M, VEYRI M, BRéGIGEON S, et al. Enquête sur la pratique du dépistage du VIH, VHB et VHC en cancérologie, France survey on HIV, HBV and HCV screening practices in cancerology, France［J］. Bull Cancer, 2021, 108(4): 369-376.

[10] [10] PHONBUPPHA J, TINIKUL R, CHAIYEN P. Use of bacterial luciferase as a reporter gene in eukaryotic systems［J］. Methods in Molecular Biology, 2021, 2274: 53-65.

[11] [11] CRABB D W, MINTH C D, DIXON J E. Assaying the reporter gene chloramphenicol acetyltransferase［J］. Methods in Enzymology, 1989, 168: 690-701.

[12] [12] ANSON D S, LIMBERIS M. An improved beta-galactosidase reporter gene［J］. Journal Biotechnology, 2004, 108(1): 17-30.

[13] [13] FLURI D A, KELM J M, LESAGE G, et al. Compact heterologous reporter proteins for mammalian cells［J］. Biotechnology and Bioengineering, 2007, 98(3): 655-667.

[14] [14] JUNG S, ALIBERTI J, GRAEMMEL P, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion［J］. Molecular Cell Biology, 2000, 20(11): 4106-4114.

[15] [15] SCHENBORN E, GROSKREUTZ D. Reporter gene vectors and assays［J］. Molecular Biotechnology, 1999, 13(1): 29-44.

[16] [16] HAYDEN M S, WEST A P, GHOSH S. SnapShot: NF-kappaB signaling pathways［J］. Cell, 2006, 127(6): 1286-1287.

[17] [17] HOESEL B, SCHMID J A. The complexity of NF-κB signaling in inflammation and cancer［J］. Molocular Cancer, 2013, 12: 86.

[18] [18] BEINKE S. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology［J］. Biochemical Journal, 2004, 382(Pt 2): 393-409.

[19] [19] TEGOWSKI M, BALDWIN A. Noncanonical NF-κB in cancer［J］. Biomedicines, 2018, 6(2): 66.

[20] [20] TANIGUCHI K. NF-κB, inflammation, immunity and cancer: coming of age［J］. Nature Reviews Immunology, 2018, 18(5): 309-324.

[21] [21] ERSTAD D J, CUSACK J C. Targeting the NF-κB pathway in cancer therapy［J］. Surgical Oncology Clinics of North America, 2013, 22(4): 705-746.

[22] [22] SUN L, YAN Y, LV H, et al. Rapamycin targets STAT3 and impacts c-Myc to suppress tumor growth［J］. Cell Chemical Biology, 2022, 9(3): 373-385.

[23] [23] SCRIBANO C M, WAN J, ESBONA K, et al. Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxel［J］. Science Translational Medicine, 2021, 13(610): 345-352.

[24] [24] PANDIT B, ROYZEN M. Recent development of prodrugs of gemcitabine［J］. Genes (Basel), 2022, 13(3): 466.

[27] [27] WOERTLER K. Tumors and tumor-like lesions of peripheral nerves［J］. Seminars Musculoskeletal Radiology, 2010, 14(5): 547-558.

[28] [28] ZLOKARNIK G, GROOTENHUIS P D, WATSON J B. High throughput P450 inhibition screens in early drug discovery［J］. Drug Discovery Today, 2005, 10(21): 1443-1450.

[29] [29] ASHWINI M, MURUGAN S B, BALAMURUGAN S, et al. Advances in molecular cloning［J］. Molecular Biology, 2016, 50(1): 3-9.